Wenjuan Tian
Overview
Explore the profile of Wenjuan Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian W, Ren Y, Lu J, Jing C, Zhang W, Li H, et al.
BMC Med
. 2024 Aug;
22(1):344.
PMID: 39183277
Background: The combination of anti-programmed death 1 (PD-1) inhibitors and tyrosine kinase inhibitors is an effective treatment strategy in endometrial cancer. We aimed to explore the efficacy and safety of...
2.
Chai B, Wu Y, Yang H, Fan B, Cao S, Zhang X, et al.
Adv Sci (Weinh)
. 2024 Apr;
11(23):e2310134.
PMID: 38634567
Intraperitoneal dissemination is the main method of epithelial ovarian cancer (EOC) metastasis, which is related to poor prognosis and a high recurrence rate. Circular RNAs (circRNAs) are a novel class...
3.
Tian W, Cao S, Zhang W, Quan C, Zhang M, Huang Y
Gynecol Endocrinol
. 2024 Mar;
40(1):2317270.
PMID: 38518807
Aims: The aim of this study was to investigate the impact of three single nucleotide polymorphisms (SNPs) within X-Ray Repair Cross Complementary Group 2 (XRCC2) gene and additional gene- abdominal...
4.
Shen W, Jing C, Tian W, Zhang W, Ren Y, Shan B, et al.
Int J Gynecol Cancer
. 2023 Sep;
33(11):1764-1770.
PMID: 37775281
Objective: This study aimed to prospectively evaluate the efficacy and safety of anlotinib in patients with platinum resistant/refractory ovarian cancer. Methods: In this prospective, single arm, phase II study, patients...
5.
Hu X, Tian W, Jiao Y, Kelley S, Wang P, Dalgarno S, et al.
J Am Chem Soc
. 2023 Sep;
145(37):20375-20380.
PMID: 37672654
Here we report the controlled self-assembly of vanadium-seamed metal-organic nanocapsules with specific metal oxidation state distributions. Three supramolecular assemblies composed of the same numbers of components including 24 metal centers...
6.
Zhao Y, Zhang H, Li Y, Ma C, Tian W, Qi X, et al.
Adv Sci (Weinh)
. 2023 Aug;
10(28):e2303108.
PMID: 37541307
Crystal transformation of metal compound cathodes during charge/discharge processes in alkali metal-ion batteries usually generates profound impact on structural stability and electrochemical performance, while the theme in anode materials, which...
7.
Chen G, Zhang Y, Wu K, Jin T, Peng C, Jiang Q, et al.
BMC Infect Dis
. 2023 Jun;
23(1):437.
PMID: 37370000
Background: The emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and subsequent Coronavirus Disease 2019 (COVID-19) pandemic has resulted in a significant global public health burden, leading to an...
8.
Shao Y, Li H, Wu Y, Wang X, Meng J, Hu Z, et al.
Cancer Lett
. 2023 May;
565:216241.
PMID: 37217070
Platinum-taxane chemotherapy is the first-line standard-of-care treatment administered to patients with epithelial ovarian cancer (EOC), and faces the major challenge of cisplatin resistance. Aurora Kinase A (AURKA) is a serine/threonine...
9.
Ren Y, Wang T, Cheng X, Ke G, Huang Y, Yang H, et al.
Ann Transl Med
. 2023 Feb;
11(2):106.
PMID: 36819505
Background: Apatinib, a small-molecule tyrosine kinase inhibitor that selectively targets vascular endothelial growth factor receptor-2, has clinical activity in recurrent/advanced gynecological cancers. However, its efficacy in uterine malignancy remains unclear....
10.
Tian W, Ji Z, Wang J, Meng J, Bi R, Ren Y, et al.
Front Oncol
. 2022 Oct;
12:1018034.
PMID: 36313640
Objective: This study was aimed to profile hotspot exonuclease domain mutations (EDMs) of the DNA polymerase ϵ gene () in endometrial cancer (EC) and to investigate the effects of EDMs...